Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy

Conclusion: 18F-DCFPyL PET/CT offers high detection rates in BCR PCa patients. PSA and PSAdt are able to predict scan positivity and disease location. Furthermore, the presence of bone or visceral lesions is associated with shorter intervals from treatment than are prostate-bed–only recurrences. These tools might guide clinicians to select the most suitable candidates for 18F-DCFPyL PET/CT imaging.

Source: Journal of Nuclear Medicine - August 1, 2022 Category: Nuclear Medicine Authors: Mena, E., Rowe, S. P., Shih, J. H., Lindenberg, L., Turkbey, B., Fourquet, A., Lin, F. I., Adler, S., Eclarinal, P., McKinney, Y. L., Citrin, D. E., Dahut, W., Wood, B. J., Chang, R., Levy, E., Merino, M., Gorin, M. A., Pomper, M. G., Pinto, P. A., Eary, Tags: Clinical Investigations Source Type: research